Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Rezolute (RZLT) has a market cap of $0.28 billion USD. According to our data, Rezolute is ranked No.6791 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.28 B |
-1.84%
|
| Dec 31, 2024 | $0.28 B |
393.45%
|
| Dec 29, 2023 | $57.54 M |
-52.03%
|
| Dec 30, 2022 | $0.12 B |
-56.69%
|
| Dec 31, 2021 | $0.28 B |
-60.13%
|
| Dec 31, 2020 | $0.69 B |
108.52%
|
| Dec 31, 2019 | $0.33 B |
27.78%
|
| Dec 31, 2018 | $0.26 B |
-89.83%
|
| Dec 29, 2017 | $2.56 B |
-11.50%
|
| Dec 30, 2016 | $2.90 B |
-31.51%
|
| Dec 31, 2015 | $4.23 B |
16.80%
|
| Dec 31, 2014 | $3.62 B |
-60.69%
|
| Dec 31, 2013 | $9.21 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Protagonist Therapeutics
PTGX
|
$2.20 B |
-0.000 M
|
USA
|
 Akebia Therapeutics
AKBA
|
$0.52 B |
0.000 M
|
USA
|
 Crinetics Pharmaceuticals
CRNX
|
$3.58 B |
0.000 M
|
USA
|
 Ascendis Pharma
ASND
|
$7.53 B |
0.000 M
|
Denmark
|
 Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
 Rhythm Pharmaceuticals
RYTM
|
$3.52 B |
0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Amicus Therapeutics
FOLD
|
$2.85 B |
0.000 M
|
USA
|
 PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
| Market Cap | = | RZLT Stock Price | * | RZLT Shares Outstanding |
| = | $4.81 | * | 57.94 M | |
| = | $0.28 B |